Engineered biomaterials for development of nucleic acid vaccines

Biomaterials Research
Jun YangXin Zhang

Abstract

Nucleic acid vaccines have attracted many attentions since they have presented some superiority over traditional vaccines. However, they could only induce moderate immunogenicity. The route and formulation of nucleic acid vaccines have strong effects on the immune response and efficiency. Numerous biomaterials are used as a tool to enhance the immunogenicity of antigens. They deliver the antigens into the cells through particle- and non-particle-mediated pathway. However, challenges remain due to lack of comprehensive understanding of the actions of these biomaterials as a carrier/adjuvant. Herein, this review focuses on the evolution of biomaterials used for nucleic acid vaccines, discusses the advantages and disadvantages for gene delivery and immunostimulation of variety of structures of the biomaterials, in order to provide new thought on rational design of carrier/adjuvant and better understanding of mechanism of action in both immunostimulatory and delivery methods.

References

Dec 1, 1983·Microbiological Reviews·A M Behbehani
Sep 11, 2002·Journal of Controlled Release : Official Journal of the Controlled Release Society·Marjo MännistöArto Urtti
Sep 13, 2003·Nature Materials·Aliasger K SalemKam W Leong
Jun 24, 2004·Proceedings of the National Academy of Sciences of the United States of America·Steven R LittleRobert Langer
Aug 5, 2004·Proceedings of the National Academy of Sciences of the United States of America·Freda K StevensonJason Rice
Nov 16, 2004·The Journal of Gene Medicine·Akin AkincRobert Langer
Apr 7, 2005·Nature Medicine·Stanley A Plotkin
May 10, 2005·The Journal of Immunology : Official Journal of the American Association of Immunologists·Sarah BuchanJason Rice
Aug 23, 2005·Journal of Controlled Release : Official Journal of the Controlled Release Society·Steven R LittleRobert Langer
Nov 18, 2005·Advances in Genetics·Margaret A Liu, Jeffrey B Ulmer
Jul 5, 2006·International Reviews of Immunology·Dominick J Laddy, David B Weiner
Jul 17, 2007·Journal of Controlled Release : Official Journal of the Controlled Release Society·Xianfeng ZhouJiacong Shen
Oct 4, 2007·Annals of the New York Academy of Sciences·Francesca FerreraGilberto Filaci
Jan 15, 2008·The Journal of Infectious Diseases·Julie E MartinBarney S Graham
Jan 26, 2008·Nature Reviews. Cancer·Jason RiceFreda K Stevenson
Mar 8, 2008·Advanced Drug Delivery Reviews·Laura J PeekCory Berkland
Jun 19, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Stanley A Plotkin
Aug 5, 2008·Recent Patents on Anti-infective Drug Discovery·Pieranna ChiarellaEmanuela Signori
Sep 11, 2008·Nature Reviews. Genetics·Michele A Kutzler, David B Weiner
Feb 19, 2009·Nanomedicine : Nanotechnology, Biology, and Medicine·Youqing ShenWilliam J Murdoch
Feb 28, 2009·Nature Reviews. Immunology·Philippa MarrackMichael W Munks
Jan 19, 2010·Proceedings of the National Academy of Sciences of the United States of America·Jai S RudraJoel H Collier
Mar 23, 2010·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Yi-Fan Ma, Ya-Wun Yang
May 26, 2010·Proceedings of the National Academy of Sciences of the United States of America·Krishnan V ChakravarthyParas N Prasad
Sep 22, 2010·Current Opinion in Allergy and Clinical Immunology·Richard WeissJosef Thalhamer
Mar 19, 2011·Expert Opinion on Drug Delivery·Malou Henriksen-LaceyDennis Christensen
May 3, 2011·Current Opinion in Immunology·Niranjan Y Sardesai, David B Weiner
May 17, 2011·Current Medicinal Chemistry·L Tomljenovic, C A Shaw
Jan 13, 2012·PloS One·Daniel X JohanssonPeter Liljeström
Jan 26, 2012·ACS Nano·Jai S RudraJoel H Collier
Apr 7, 2012·Bioorganic & Medicinal Chemistry Letters·Baohua HuangJames R Baker
May 9, 2012·International Journal of Pharmaceutics·J F Correia-PintoM J Alonso
Jun 30, 2012·International Journal of Nanomedicine·Xun SunZhirong Zhang
Aug 14, 2012·European Journal of Immunology·Evita V GrantNorman L Letvin
Aug 22, 2012·Proceedings of the National Academy of Sciences of the United States of America·Andrew J GeallChristian W Mandl
Sep 27, 2012·Molecular Therapy : the Journal of the American Society of Gene Therapy·Charlotte PollardStefaan De Koker
Oct 26, 2012·Biotechnology and Bioengineering·Bo ZhangYouqing Shen
Dec 21, 2012·Expert Opinion on Drug Delivery·Soma Patnaik, Kailash C Gupta

❮ Previous
Next ❯

Citations

Jun 2, 2020·Expert Opinion on Drug Delivery·Rosana Simón-VázquezÁfrica González-Fernández
Apr 30, 2017·Chemical Science·Lev A Dykman, Nikolai G Khlebtsov
Sep 6, 2018·Molecular Biotechnology·Saeed KhaliliFatemeh Malaei
Apr 11, 2021·FEMS Yeast Research·Anna Jéssica Duarte SilvaAntonio Carlos Freitas
Jun 29, 2021·Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology·Michael A LuzuriagaJeremiah J Gassensmith

❮ Previous
Next ❯

Methods Mentioned

BETA
gene gun
transfection

Related Concepts

Related Feeds

Avian Influenza: Innate Immune Adjuvant (ASM)

Adjuvants systems that are added to vaccines against avian influenza have be explored to enhance the innate immune system response against the virus. Here is the latest research on avian influenza and the innate immune adjuvant.

Avian Influenza: Innate Immune Adjuvant

Adjuvants systems that are added to vaccines against avian influenza have be explored to enhance the innate immune system response against the virus. Here is the latest research on avian influenza and the innate immune adjuvant.

Related Papers

Vaccine
Liang ZhaoAnton P J Middelberg
Methods : a Companion to Methods in Enzymology
Mehfuz ZamanIstvan Toth
Der Hautarzt; Zeitschrift für Dermatologie, Venerologie, und verwandte Gebiete
E Blitstein-Willinger
© 2021 Meta ULC. All rights reserved